Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000661912 | SCV000784234 | uncertain significance | Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000661913 | SCV000784235 | uncertain significance | Lymphatic malformation 6 | 2018-03-05 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002227195 | SCV002506282 | uncertain significance | not provided | 2022-02-11 | criteria provided, single submitter | clinical testing | The PIEZO1 c.3107G>A; p.Arg1036His variant (rs769506340), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 548456). This variant is found in the general population with an overall allele frequency of 0.01% (21/185990 alleles) in the Genome Aggregation Database. The arginine at codon 1036 is moderately conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.226). Given the lack of clinical and functional data, the significance of the p.Arg1036His variant is uncertain at this time. |
Ambry Genetics | RCV002530589 | SCV003642271 | uncertain significance | Inborn genetic diseases | 2022-08-16 | criteria provided, single submitter | clinical testing | The c.3107G>A (p.R1036H) alteration is located in exon 22 (coding exon 22) of the PIEZO1 gene. This alteration results from a G to A substitution at nucleotide position 3107, causing the arginine (R) at amino acid position 1036 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |